A review of eGFR reporting after 6 months in practice.

J Clin Pathol

Department of Clinical Biochemistry, Wirral University Teaching Hospital NHS Foundation Trust, Arrowe Park Hospital, Upton, UK.

Published: April 2009

Background: Following the introduction of routine calculation of estimated glomerular filtration rate (eGFR) from all serum creatinine values in samples received from general practice it was noted that there was a preponderance of values consistent with chronic kidney disease (CKD) stage 3 or higher.

Methods: A review was conducted of all eGFR values from 51 314 individuals received from primary care during October 2006 to April 2007.

Results: It was found that more than 25% of eGFR results indicated CKD stage 3 or higher. The median age in this group was 64 years (range 18-104 years) while that of the local general population according to the 2001 census was 40 years (range 18-104 years); these ages were statistically significantly different (p<0.001). There was no difference between the groups with regard to gender. The eGFR data were therefore corrected for age distribution, and an estimated prevalence of 5.6% of eGFR consistent with CKD stage 3 was found. This was a higher proportion than estimates of CKD suggested before the introduction of eGFR.

Conclusions: The higher proportion of CKD stage 3 may be due to difference in age and gender in populations studied, as there is a marked effect of age on calculated eGFR values found.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jcp.2008.058537DOI Listing

Publication Analysis

Top Keywords

ckd stage
8
years range
8
range 18-104
8
18-104 years
8
review egfr
4
egfr reporting
4
reporting months
4
months practice
4
practice background
4
background introduction
4

Similar Publications

Correlation Between Indoxyl Sulfate in Chronic Kidney Disease and Olfactory Dysfunction.

Iran J Otorhinolaryngol

January 2025

Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Jl. Dr. Mansur No. 5, Medan, 20155, INDONESIA.

Introduction: Olfactory dysfunction is prevalent among individuals with chronic kidney disease (CKD), with prevalence escalating alongside disease severity. The uremic toxin we observed in this study is Indoxyl sulfate (IS), a potent uremic toxin that markedly accumulates in the plasma of patients with chronic insufficiency. Olfactory damage may occur in the setting of neuronal damage due to renal failure.

View Article and Find Full Text PDF

Background: We aimed to explore changes in decision-related brain microstructure, brain functional activities, and functional connectivity, and their correlations with cognitive function in end-stage kidney disease (ESKD) patients undergoing peritoneal dialysis (PD). Furthermore, the impact of dialysis on these changes was examined.

Methods: Thirty ESKD patients undergoing PD, 20 chronic kidney disease (CKD) stage 5 patients without dialysis (predialysis CKD stage 5), and 30 healthy controls (HC) were recruited for the study.

View Article and Find Full Text PDF

Background: Patients with end-stage kidney disease (ESKD) frequently visit the emergency department (ED) due to complications from comorbidities and dialysis. This study aimed to investigate the clinical outcomes and patterns of ED visits, hospitalizations, and in-hospital mortality among ED visits by ESKD patients in South Korea.

Methods: This study utilized data from the National Emergency Department Information System from 2019 to 2021.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is a prevalent global health issue affecting millions of patients worldwide, impacting quality of life, impeding physical and psychological well-being, causing financial stress, and increasing mortality rates. This study aimed to highlight the prevalence of CKD and its associated risk factors across Saudi Arabia.

Method: This is a cross-sectional study conducted from 2015 to 2022, using data from 42 branches of a major network of diagnostic laboratories in Saudi Arabia, covering the country's 13 administrative areas.

View Article and Find Full Text PDF

Survival in patients with CKD 3-5 after 12 months of exercise training - a post-hoc analysis of the RENEXC trial.

BMC Nephrol

January 2025

Department of Nephrology, Department of Clinical Sciences Lund, Nephrology, Faculty of Medicine, Skåne University Hospital and Lund University, Lund, Sweden.

Background: Physical performance is low and physical activity declines in people with chronic kidney disease (CKD). Both factors are associated with decreased survival. Our hypothesis was that improved physical performance after 12 months of exercise training would result in better survival in patients with CKD stages 3 to 5 not on kidney replacement therapy (KRT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!